低冠脉血流与心肌质量比值预测症状性高血压患者心力衰竭
本研究为回顾性队列(n=346),纳入因胸痛和/或呼吸困难行PET心肌灌注显像的高血压患者,排除梗阻性冠心病、心衰、心肌病或EF<40%者。以充血性心肌血流量与左室质量指数(flow/mass ratio)评估灌注与代谢需求匹配,发现低比值独立关联左室扩大、EF降低及心衰住院、死亡风险升高。
要点
- flow/mass比值低于中位数者心衰住院风险调整HR 2.47(95%CI 1.24-4.93;P=0.01)。
- 低flow/mass比值独立关联左室舒张末容积增大(β=-0.44,P<0.001)和EF降低(β=0.33,P<0.001)。
- 该指标可在无梗阻性冠心病的高血压患者中识别亚临床高血压心脏病和心衰/死亡高风险。
核心结论
- 反映心肌灌注不足以匹配整体代谢需求的flow/mass比值,可识别症状性高血压患者中的亚临床高血压心脏病及心衰和死亡风险升高。
研究设计与样本
- 回顾性队列研究(n=346),纳入因胸痛和/或呼吸困难行临床PET心肌灌注显像的高血压患者,排除病史或PET灌注提示梗阻性冠心病(summed stress score<3)、心衰、心肌病或EF<40%者。
主要发现
- flow/mass比值越低,左室舒张末容积越大(β=-0.44,P<0.001)、收缩末容积越大(β=-0.48,P<0.001)、EF越低(β=0.33,P<0.001)。
- flow/mass比值低于中位数与心衰住院调整HR 2.47(95%CI 1.24-4.93;P=0.01)相关。
- flow/mass比值低于中位数与全因死亡调整HR 1.95(95%CI 1.12-3.41;P=0.02)及复合终点调整HR 2.20(95%CI 1.39-3.49;P<0.001)相关。
临床怎么用
- 对无梗阻性冠心病但有症状的高血压患者,可考虑用PET测量的充血性心肌血流量与左室质量比值评估亚临床高血压心脏病风险。
- flow/mass比值低于中位数提示心衰住院和死亡风险升高,可辅助风险分层。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The transition from hypertension to heart failure (HF) remains poorly understood. We hypothesized that insufficient perfusion to match global metabolic demand, reflected by a low ratio of myocardial blood flow to global myocardial mass, may be a HF risk marker. METHODS AND RESULTS: A retrospective cohort (n = 346) of patients with hypertension who underwent clinical positron emission tomography (PET) myocardial perfusion imaging for chest pain and/or dyspnoea at Brigham and Women's Hospital (Boston, MA, USA) were studied. Patients without obstructive coronary artery disease by history or PET perfusion (summed stress score <3), HF, cardiomyopathy, or ejection fraction (EF) <40% were followed for HF hospitalization (primary outcome), all-cause death, and their composite. Myocardial blood flow, left ventricular (LV) mass, volumes, and EF were obtained from PET, and a 'flow/mass ratio' was determined as hyperaemic myocardial blood flow over LV mass indexed to body surface area. A lower flow/mass ratio was independently associated with larger end-diastolic (β = -0.44, P < 0.001) and end-systolic volume (β = -0.48, P < 0.001) and lower EF (β = 0.33, P < 0.001). A flow/mass ratio below the median was associated with an adjusted hazard ratio of 2.47 [95% confidence interval (CI) 1.24-4.93; P = 0.01] for HF hospitalization, 1.95 (95% CI 1.12-3.41; P = 0.02) for death, and 2.20 (95% CI 1.39-3.49; P < 0.001) for the composite. CONCLUSION: An integrated physiological measure of insufficient myocardial perfusion to match global metabolic demand identifies subclinical hypertensive heart disease and elevated risk of HF and death in symptomatic patients with hypertension but without flow-limiting coronary artery disease.
引用
- Brown JM, Zhou W, Weber B, et al. Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. Eur Heart J. 2022. PMID: 34491335. doi:10.1093/eurheartj/ehab610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。